Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 years.
Saved in:
| Title: | Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 years. |
|---|---|
| Authors: | Durier C; INSERM US19, Villejuif, France. christine.durier@inserm.fr., Ninove L; Unité des Virus Émergents (UVE), Aix Marseille Univ, IRD 190, INSERM 1207, Marseille, France., Lefebvre M; Maladies Infectieuses et Tropicales, Centre de Prévention des Maladies Infectieuses et Transmissibles CHU de Nantes, INSERM CIC1413, Nantes, France., Radenne A; Assistance Publique Hôpitaux de Paris, Unité de Recherche Clinique des Hôpitaux Universitaires Pitié Salpêtrière -Hôpitaux Universitaires Pitié Salpêtrière - Charles Foix, Paris, France., Desaint C; INSERM US19, Villejuif, France.; INSERM CIC 1417 Cochin Pasteur, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Innovative Clinical Research Network in Vaccinology, Université de Paris, Sorbonne Paris Cité, Paris, France., Ropers J; Assistance Publique Hôpitaux de Paris, Unité de Recherche Clinique des Hôpitaux Universitaires Pitié Salpêtrière -Hôpitaux Universitaires Pitié Salpêtrière - Charles Foix, Paris, France., Bauer R; INSERM US19, Villejuif, France., Lebbah S; Assistance Publique Hôpitaux de Paris, Unité de Recherche Clinique des Hôpitaux Universitaires Pitié Salpêtrière -Hôpitaux Universitaires Pitié Salpêtrière - Charles Foix, Paris, France., Carette D; INSERM US19, Villejuif, France., Lachatre M; INSERM CIC 1417 Cochin Pasteur, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Innovative Clinical Research Network in Vaccinology, Université de Paris, Sorbonne Paris Cité, Paris, France., Lecompte AS; Maladies Infectieuses et Tropicales, Centre de Prévention des Maladies Infectieuses et Transmissibles CHU de Nantes, INSERM CIC1413, Nantes, France., Deplanque D; INSERM, CHU Lille, CIC 1403 - Centre d'investigation Clinique, Univ. Lille, Lille, France., Botelho-Nevers E; Infectious Diseases Department, CIC 1408 INSERM University Hospital of Saint-Etienne, University Hospital of Saint-Etienne, Saint-Etienne, France., Conrad A; Department Maladies Infectieuses et Tropicales, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Univ. Claude Bernard Lyon I, CNRS, UMR5308, ENS de Lyon, Univ Lyon, Lyon, France.; Centre International de Recherche en Infectiologie (CIRI), INSERM U1111, Université Claude Bernard Lyon I, Lyon, France., Dussol B; Centre d'Investigation Clinique 1409, Hôpital de la Conception, INSERM- Hôpitaux Universitaires de Marseille - Aix Marseille Université, Marseille, France., Maakaroun-Vermesse Z; Centre de Vaccination CHU de Tours, Centre d'Investigation Clinique CIC 1415, INSERM, CHRU de Tours, Tours, France., Melica G; Service d'Immunologie Clinique et Maladies Infectieuses, APHP, Hôpital Henri Mondor, Créteil, France.; Centre d'Investigation Clinique 1430 INSERM, APHP, Hôpital Henri Mondor, Créteil, France., Nicolas JF; Centre International de Recherche en Infectiologie (CIRI), INSERM U1111, Université Claude Bernard Lyon I, Lyon, France.; CHU Lyon-Sud, Pierre-Bénite, France., Verdon R; Service de Maladies Infectieuses, CHU de Caen, Caen, France.; Dynamicure INSERM, UMR 1311, Normandie Univ, UNICAEN, Caen, France., Kiladjian J; AP-HP, Hôpital Saint-Louis, Centre d'Investigations Cliniques, INSERM, CIC1427, Université Paris Cité, Paris, France., Loubet P; VBMI, INSERM U1047, Department of Infectious and Tropical Diseases, Université de Montpellier, CHU Nîmes, Univ Montpellier, Nîmes, France., Schmidt-Mutter C; Inserm CIC 1434, CHU Strasbourg, Strasbourg, France., Dualé C; Centre d'Investigation Clinique (INSERM CIC1405), CHU Clermont-Ferrand, Clermont-Ferrand, France., Ansart S; Centre d'Investigation Clinique CIC 1412, INSERM, CHU Brest, Brest, France., Priet S; Unité des Virus Émergents (UVE), Aix Marseille Univ, IRD 190, INSERM 1207, Marseille, France., Levier A; ANRS | Emerging Infectious Diseases, Paris, France., Molino D; INSERM CIC 1417 Cochin Pasteur, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Innovative Clinical Research Network in Vaccinology, Université de Paris, Sorbonne Paris Cité, Paris, France., Vieillard LV; INSERM CIC 1417 Cochin Pasteur, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Innovative Clinical Research Network in Vaccinology, Université de Paris, Sorbonne Paris Cité, Paris, France., Parfait B; Fédération des Centres de Ressources Biologiques - Plateforme de Ressources Biologiques APHP -Université de Paris, Centre de Ressources Biologiques Cochin, Hôpital Cochin, Paris, France., Lelièvre JD; INSERM U955, Vaccine Research Institute, Créteil, France., Tartour E; APHP, Hôpital Européen Georges Pompidou, INSERM U970, PARCC, Université de Paris, Paris, France., de Lamballerie X; Unité des Virus Émergents (UVE), Aix Marseille Univ, IRD 190, INSERM 1207, Marseille, France., Launay O; INSERM CIC 1417 Cochin Pasteur, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Innovative Clinical Research Network in Vaccinology, Université de Paris, Sorbonne Paris Cité, Paris, France. |
| Corporate Authors: | ANRS0002S CoviCompareP Group, AP-HP CoviCompareM Group, Biological resource centers, Laboratories, Trial coordination, Sponsor, Scientific Committee |
| Source: | Scientific reports [Sci Rep] 2022 Nov 27; Vol. 12 (1), pp. 20373. Date of Electronic Publication: 2022 Nov 27. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36437298 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 years. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Durier+C%22">Durier C</searchLink>; INSERM US19, Villejuif, France. christine.durier@inserm.fr.<br /><searchLink fieldCode="AU" term="%22Ninove+L%22">Ninove L</searchLink>; Unité des Virus Émergents (UVE), Aix Marseille Univ, IRD 190, INSERM 1207, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Lefebvre+M%22">Lefebvre M</searchLink>; Maladies Infectieuses et Tropicales, Centre de Prévention des Maladies Infectieuses et Transmissibles CHU de Nantes, INSERM CIC1413, Nantes, France.<br /><searchLink fieldCode="AU" term="%22Radenne+A%22">Radenne A</searchLink>; Assistance Publique Hôpitaux de Paris, Unité de Recherche Clinique des Hôpitaux Universitaires Pitié Salpêtrière -Hôpitaux Universitaires Pitié Salpêtrière - Charles Foix, Paris, France.<br /><searchLink fieldCode="AU" term="%22Desaint+C%22">Desaint C</searchLink>; INSERM US19, Villejuif, France.; INSERM CIC 1417 Cochin Pasteur, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Innovative Clinical Research Network in Vaccinology, Université de Paris, Sorbonne Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Ropers+J%22">Ropers J</searchLink>; Assistance Publique Hôpitaux de Paris, Unité de Recherche Clinique des Hôpitaux Universitaires Pitié Salpêtrière -Hôpitaux Universitaires Pitié Salpêtrière - Charles Foix, Paris, France.<br /><searchLink fieldCode="AU" term="%22Bauer+R%22">Bauer R</searchLink>; INSERM US19, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Lebbah+S%22">Lebbah S</searchLink>; Assistance Publique Hôpitaux de Paris, Unité de Recherche Clinique des Hôpitaux Universitaires Pitié Salpêtrière -Hôpitaux Universitaires Pitié Salpêtrière - Charles Foix, Paris, France.<br /><searchLink fieldCode="AU" term="%22Carette+D%22">Carette D</searchLink>; INSERM US19, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Lachatre+M%22">Lachatre M</searchLink>; INSERM CIC 1417 Cochin Pasteur, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Innovative Clinical Research Network in Vaccinology, Université de Paris, Sorbonne Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Lecompte+AS%22">Lecompte AS</searchLink>; Maladies Infectieuses et Tropicales, Centre de Prévention des Maladies Infectieuses et Transmissibles CHU de Nantes, INSERM CIC1413, Nantes, France.<br /><searchLink fieldCode="AU" term="%22Deplanque+D%22">Deplanque D</searchLink>; INSERM, CHU Lille, CIC 1403 - Centre d'investigation Clinique, Univ. Lille, Lille, France.<br /><searchLink fieldCode="AU" term="%22Botelho-Nevers+E%22">Botelho-Nevers E</searchLink>; Infectious Diseases Department, CIC 1408 INSERM University Hospital of Saint-Etienne, University Hospital of Saint-Etienne, Saint-Etienne, France.<br /><searchLink fieldCode="AU" term="%22Conrad+A%22">Conrad A</searchLink>; Department Maladies Infectieuses et Tropicales, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Univ. Claude Bernard Lyon I, CNRS, UMR5308, ENS de Lyon, Univ Lyon, Lyon, France.; Centre International de Recherche en Infectiologie (CIRI), INSERM U1111, Université Claude Bernard Lyon I, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Dussol+B%22">Dussol B</searchLink>; Centre d'Investigation Clinique 1409, Hôpital de la Conception, INSERM- Hôpitaux Universitaires de Marseille - Aix Marseille Université, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Maakaroun-Vermesse+Z%22">Maakaroun-Vermesse Z</searchLink>; Centre de Vaccination CHU de Tours, Centre d'Investigation Clinique CIC 1415, INSERM, CHRU de Tours, Tours, France.<br /><searchLink fieldCode="AU" term="%22Melica+G%22">Melica G</searchLink>; Service d'Immunologie Clinique et Maladies Infectieuses, APHP, Hôpital Henri Mondor, Créteil, France.; Centre d'Investigation Clinique 1430 INSERM, APHP, Hôpital Henri Mondor, Créteil, France.<br /><searchLink fieldCode="AU" term="%22Nicolas+JF%22">Nicolas JF</searchLink>; Centre International de Recherche en Infectiologie (CIRI), INSERM U1111, Université Claude Bernard Lyon I, Lyon, France.; CHU Lyon-Sud, Pierre-Bénite, France.<br /><searchLink fieldCode="AU" term="%22Verdon+R%22">Verdon R</searchLink>; Service de Maladies Infectieuses, CHU de Caen, Caen, France.; Dynamicure INSERM, UMR 1311, Normandie Univ, UNICAEN, Caen, France.<br /><searchLink fieldCode="AU" term="%22Kiladjian+J%22">Kiladjian J</searchLink>; AP-HP, Hôpital Saint-Louis, Centre d'Investigations Cliniques, INSERM, CIC1427, Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Loubet+P%22">Loubet P</searchLink>; VBMI, INSERM U1047, Department of Infectious and Tropical Diseases, Université de Montpellier, CHU Nîmes, Univ Montpellier, Nîmes, France.<br /><searchLink fieldCode="AU" term="%22Schmidt-Mutter+C%22">Schmidt-Mutter C</searchLink>; Inserm CIC 1434, CHU Strasbourg, Strasbourg, France.<br /><searchLink fieldCode="AU" term="%22Dualé+C%22">Dualé C</searchLink>; Centre d'Investigation Clinique (INSERM CIC1405), CHU Clermont-Ferrand, Clermont-Ferrand, France.<br /><searchLink fieldCode="AU" term="%22Ansart+S%22">Ansart S</searchLink>; Centre d'Investigation Clinique CIC 1412, INSERM, CHU Brest, Brest, France.<br /><searchLink fieldCode="AU" term="%22Priet+S%22">Priet S</searchLink>; Unité des Virus Émergents (UVE), Aix Marseille Univ, IRD 190, INSERM 1207, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Levier+A%22">Levier A</searchLink>; ANRS | Emerging Infectious Diseases, Paris, France.<br /><searchLink fieldCode="AU" term="%22Molino+D%22">Molino D</searchLink>; INSERM CIC 1417 Cochin Pasteur, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Innovative Clinical Research Network in Vaccinology, Université de Paris, Sorbonne Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Vieillard+LV%22">Vieillard LV</searchLink>; INSERM CIC 1417 Cochin Pasteur, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Innovative Clinical Research Network in Vaccinology, Université de Paris, Sorbonne Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Parfait+B%22">Parfait B</searchLink>; Fédération des Centres de Ressources Biologiques - Plateforme de Ressources Biologiques APHP -Université de Paris, Centre de Ressources Biologiques Cochin, Hôpital Cochin, Paris, France.<br /><searchLink fieldCode="AU" term="%22Lelièvre+JD%22">Lelièvre JD</searchLink>; INSERM U955, Vaccine Research Institute, Créteil, France.<br /><searchLink fieldCode="AU" term="%22Tartour+E%22">Tartour E</searchLink>; APHP, Hôpital Européen Georges Pompidou, INSERM U970, PARCC, Université de Paris, Paris, France.<br /><searchLink fieldCode="AU" term="%22de+Lamballerie+X%22">de Lamballerie X</searchLink>; Unité des Virus Émergents (UVE), Aix Marseille Univ, IRD 190, INSERM 1207, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Launay+O%22">Launay O</searchLink>; INSERM CIC 1417 Cochin Pasteur, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Innovative Clinical Research Network in Vaccinology, Université de Paris, Sorbonne Paris Cité, Paris, France. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22ANRS0002S+CoviCompareP+Group%22">ANRS0002S CoviCompareP Group</searchLink><br /><searchLink fieldCode="CA" term="%22AP-HP+CoviCompareM+Group%22">AP-HP CoviCompareM Group</searchLink><br /><searchLink fieldCode="CA" term="%22Biological+resource+centers%22">Biological resource centers</searchLink><br /><searchLink fieldCode="CA" term="%22Laboratories%22">Laboratories</searchLink><br /><searchLink fieldCode="CA" term="%22Trial+coordination%22">Trial coordination</searchLink><br /><searchLink fieldCode="CA" term="%22Sponsor%22">Sponsor</searchLink><br /><searchLink fieldCode="CA" term="%22Scientific+Committee%22">Scientific Committee</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101563288%22">Scientific reports</searchLink> [Sci Rep] 2022 Nov 27; Vol. 12 (1), pp. 20373. <i>Date of Electronic Publication: </i>2022 Nov 27. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101563288 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2045-2322 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220452322%22">20452322 </searchLink><i>NLM ISO Abbreviation: </i>Sci Rep <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36437298 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41598-022-24409-w Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 20373 Titles: – TitleFull: Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 years. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Durier C – PersonEntity: Name: NameFull: Ninove L – PersonEntity: Name: NameFull: Lefebvre M – PersonEntity: Name: NameFull: Radenne A – PersonEntity: Name: NameFull: Desaint C – PersonEntity: Name: NameFull: Ropers J – PersonEntity: Name: NameFull: Bauer R – PersonEntity: Name: NameFull: Lebbah S – PersonEntity: Name: NameFull: Carette D – PersonEntity: Name: NameFull: Lachatre M – PersonEntity: Name: NameFull: Lecompte AS – PersonEntity: Name: NameFull: Deplanque D – PersonEntity: Name: NameFull: Botelho-Nevers E – PersonEntity: Name: NameFull: Conrad A – PersonEntity: Name: NameFull: Dussol B – PersonEntity: Name: NameFull: Maakaroun-Vermesse Z – PersonEntity: Name: NameFull: Melica G – PersonEntity: Name: NameFull: Nicolas JF – PersonEntity: Name: NameFull: Verdon R – PersonEntity: Name: NameFull: Kiladjian J – PersonEntity: Name: NameFull: Loubet P – PersonEntity: Name: NameFull: Schmidt-Mutter C – PersonEntity: Name: NameFull: Dualé C – PersonEntity: Name: NameFull: Ansart S – PersonEntity: Name: NameFull: Priet S – PersonEntity: Name: NameFull: Levier A – PersonEntity: Name: NameFull: Molino D – PersonEntity: Name: NameFull: Vieillard LV – PersonEntity: Name: NameFull: Parfait B – PersonEntity: Name: NameFull: Lelièvre JD – PersonEntity: Name: NameFull: Tartour E – PersonEntity: Name: NameFull: de Lamballerie X – PersonEntity: Name: NameFull: Launay O IsPartOfRelationships: – BibEntity: Dates: – D: 27 M: 11 Text: 2022 Nov 27 Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 2045-2322 Numbering: – Type: volume Value: 12 – Type: issue Value: 1 Titles: – TitleFull: Scientific reports Type: main |
| ResultId | 1 |